Header

UZH-Logo

Maintenance Infos

Publications for Antinori, A

Navigate back| Up a level
Export as
Group by:
Number of items: 5.

2017

Wang, Qing; De Luca, Andrea; Smith, Colette; Zangerle, Robert; Sambatakou, Helen; Bonnet, Fabrice; Smit, Colette; Schommers, Philipp; Thornton, Alicia; Berenguer, Juan; Peters, Lars; Spagnuolo, Vincenzo; Ammassari, Adriana; Antinori, Andrea; Roldan, Eugenia Quiros; Mussini, Cristina; Miro, Jose M; Konopnicki, Deborah; Fehr, Jan; Campbell, Maria A; Termote, Monique; Bucher, Heiner C; Hepatitis Coinfection and Non Hodgkin Lymphoma project team for (2017). Chronic hepatitis B and C virus infection and risk for non-hodgkin lymphoma in HIV-infected patients: a cohort study. Annals of Internal Medicine, 166(1):9-17.

2015

Antinori, Andrea; Clarke, Amanda; Svedhem-Johansson, Veronika; Arribas, José R; Arenas-Pinto, Alejandro; Fehr, Jan; Gerstoft, Jan; Horban, Andrzej; Clotet, Bonaventura; Ripamonti, Diego; Girard, Pierre-Marie; Hill, Andrew M; Moecklinghoff, Christiane (2015). Week 48 efficacy and central nervous system analysis of darunavir/ritonavir monotherapy versus darunavir/ritonavir with two nucleoside analogues. AIDS, 29(14):1811-1820.

2014

Clotet, Bonaventura; Feinberg, Judith; van Lunzen, Jan; Khuong-Josses, Marie-Aude; Antinori, Andrea; Dumitru, Irina; Pokrovskiy, Vadim; Fehr, Jan; Ortiz, Roberto; Saag, Michael; Harris, Julia; Brennan, Clare; Fujiwara, Tamio; Min, Sherene (2014). Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study. Lancet, 383(9936):2222-31.

2011

Wittkop, L; Günthard, H F; de Wolf, F; Dunn, D; Cozzi-Lepri, A; de Luca, A; Kücherer, C; Obel, N; von Wyl, V; Masquelier, B; Stephan, C; Torti, C; Antinori, A; García, F; Judd, A; Porter, K; Thiébaut, R; Castro, H; van Sighem, A I; Colin, C; Kjaer, J; Lundgren, J D; Paredes, R; Pozniak, A; Clotet, B; Phillips, A; Pillay, D; Chêne, G (2011). Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study. Lancet Infectious Diseases, 11(5):363-371.

2010

Lodwick, R; Costagliola, D; Reiss, P; Torti, C; Teira, R; Dorrucci, M; Ledergerber, B; Mocroft, A; Podzamczer, D; Cozzi-Lepri, A; Obel, N; Masquelier, B; Staszewski, S; García, F; De Wit, S; Castagna, A; Antinori, A; Judd, A; Ghosn, J; Touloumi, G; Mussini, C; Duval, X; Ramos, J; Meyer, L; Warsawski, J; Thorne, C; Masip, J; Pérez-Hoyos, S; Pillay, D; van Sighem, A; Lo Caputo, S; Günthard, H; Paredes, R; De Luca, A; Paraskevis, D; Fabre-Colin, C; Kjaer, J; Chêne, G; Lundgren, J D; Phillips, A N (2010). Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years. Archives of Internal Medicine, 170(5):410-419.

This list was generated on Sat Jun 23 11:08:31 2018 CEST.